Search research articles
Contact Us
Filters
Showing results (171-180 of 248) with videos related to
Page
of 25
Sort By:
Cancer Immunology Research
|
February 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors
John R Lozada, Atef Ali, Christine Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
E I Heath, B A Burtness, R F Heitmiller, et al.
Urology
|
February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer
Elisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2019
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Jonathan E Rosenberg, Peter H O'Donnell, Arjun V Balar, et al.
Urologic Oncology
|
June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes
Earle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Investigational New Drugs
|
February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma
Elisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
Human Genetics
|
July 2, 2009
Results from a prostate cancer admixture mapping study in African-American men
Cathryn Hufford Bock, Ann G Schwartz, Julie J Ruterbusch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 18, 2018
Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis
Hasini A Kalpage, Viktoriia Bazylianska, Maurice A Recanati, et al.
Cancer Research
|
March 15, 2008
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
Duyen T Dang, Sang Y Chun, Kyunghee Burkitt, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 248) with videos related to
Sort By:
Page
of 25
Cancer Immunology Research
|
February 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors
John R Lozada, Atef Ali, Christine Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
E I Heath, B A Burtness, R F Heitmiller, et al.
Urology
|
February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer
Elisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R Aggarwal, Michael T Schweizer, David M Nanus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2019
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Jonathan E Rosenberg, Peter H O'Donnell, Arjun V Balar, et al.
Urologic Oncology
|
June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes
Earle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Investigational New Drugs
|
February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma
Elisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.
Human Genetics
|
July 2, 2009
Results from a prostate cancer admixture mapping study in African-American men
Cathryn Hufford Bock, Ann G Schwartz, Julie J Ruterbusch, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 18, 2018
Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis
Hasini A Kalpage, Viktoriia Bazylianska, Maurice A Recanati, et al.
Cancer Research
|
March 15, 2008
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
Duyen T Dang, Sang Y Chun, Kyunghee Burkitt, et al.
Page
of 25